All posts by imreal

Pamela O’Rourke Selected as a 2020 Most Admired CEO Honoree by Houston Business Journal


Pamela Chambers O’Rourke, Founder and CEO of ICON Information Consultants, LP, has been named as a 2020 Most Admired CEO Honoree, an award which honors outstanding and admirable Houston-area CEOs. Judges scored each candidate based on his or her contribution to company success, civic involvement, career achievement and more. The judges selected 31 for-profit leaders and 19 nonprofit leaders for this year’s award. The 50 honorees will be recognized at a virtual event on August 20.

“It is an honor to be selected as one of the most admired CEOs by the Houston Business Journal,” said Pamela Chambers O’Rourke, Founder and CEO. She continued, “this is a challenging year for everyone, and it’s wonderful to have a reason to celebrate.”

The Most Admired CEOs represent multiple industries including professional services, health care systems, real estate companies, charter schools, hospitality companies, builders, colleges and more.

O’Rourke values giving back to the community. Under her leadership, ICON has a long history of funding scholarships and mentoring through the University of Houston, hosting educational events, and providing college students with internship opportunities. As a female entrepreneur, you can find O’Rourke coaching other business-minded women on how to build businesses. In addition, ICON’s executive team and employees are out in the community giving back through hosting charity drives, helping those at career transition points with resume and interviewing skills, and volunteering at local animal shelters. Furthermore, Pamela believes in helping female entrepreneurs achieve their career goals. Over the last 15 years, Pamela has contributed more than $750,000 in sponsorships to Women Business Enterprise (“WBE”) events, including at conferences, retreats, business fairs, and industry events.

O’Rourke has received numerous awards. She was named as a 2019 Women Who Mean Business honoree. ICON Information Consultants, LP, has earned the top spot as the largest woman-owned business in the area for three consecutive years. In 2011 she was inducted into the WBE Hall of Fame by the American Institute of Diversity and Commerce (AIDC). Other awards include the WBENC WBE Star Award (2008), WBC-Southwest’s WBE Advocate of the Year Award (2013) and WBE of the Year for the over $5-million category (2011 and 2013); the WBEA Supplier of the Year (over $10 million) in 2014 and 2010, and the WBEA Woman Advocate of the Year in 2009. ICON Consultants has been an active participant and supporter of the Women’s Business Enterprise National Council (WBENC), a tremendous resource and a strong advocate for women-owned businesses.

A native Houstonian, O’Rourke received her Management Information Systems (MIS) degree from the University of Houston, where she was recognized in 2016 with a Distinguished Alumni Award at The University of Houston Alumni Association 62nd Annual Awards Gala. The award is presented to alums whose professional accomplishments bring prestige to the university. O’Rourke has received other business awards over the years, including the U.S. Small Business Administration’s 2005 “Women in Business Champion of the Year” and the “Ernst & Young Entrepreneur of the Year 2009 Award” in the Business Services and Staffing category for the Houston and Gulf Coast Area. She has been awarded annually in the 50 Fastest-Growing Women-Owned/Led Companies list by the Women Presidents’ Organization and American Express since inception in 2005.

About ICON Information Consultants

Always at the forefront of technology, ICON Information Consultants has an end-to-end direct sourcing solution that includes AI based matching technology and a database of over 17MM+ US based candidates. From staff augmentation to payroll and IC management services, ICON specializes in identifying, recruiting, placing, and managing professionals in the areas of IT, Finance, Accounting, Human Resources, Procurement and Project Management. Headquartered in Houston, Texas, ICON, has gained its superior reputation by focusing its efforts on excellent customer service to clients, timely and thorough responses and high values and ethics throughout the company. As a result, ICON has 3,200+ consultants across the U.S. and Canada and have reached a “Top Tier” or preferred vendor status with most of their clients. For more information, visit http://www.ICONconsultants.com.

Share article on social media or email:

Norix Introduces New Prodigy Furniture Line


Prodigy Bedroom Collection

With the new Prodigy line, we enhance the sensory experience and the reassurance of a home setting without sacrificing the need for safety, durability and the ability to be sanitized.

Norix Introduces New Prodigy Furniture Line for Behavioral Health Environments

  • Features TruGrain™ technology for enhanced home-like feel
  • Evolution of design from the highly successful Attenda furniture line
  • Safe, durable, and recyclable/made from recycled materials

Norix, Inc., has introduced its new Prodigy collection of furniture designed for residential and inpatient behavioral health facilities. Building on the success of its Attenda furniture line, originally introduced in 2007, the Prodigy collection features bedroom furniture designed to humanize challenging environments of inpatient and residential behavioral health facilities.

The Prodigy line features a proprietary TruGrain™ wood-grain texture and natural color variability that emulates the look and feel of home furnishings, but with the durability and safety necessary for healthcare.

“We know that comfort and familiarity can be helpful for residents of behavioral health facilities,” said Scott Karl, President and CEO of Norix, Inc. “With the new Prodigy line, we enhance the sensory experience and the reassurance of a home setting without sacrificing the need for safety, durability and the ability to be sanitized.”

The Department of Veterans Affairs’ Mental Health Facilities Design Guide (2010) recommends “design approaches that incorporate home-like, non-institutional and patient-centered environments that imbue healing, familiarity, and a sense of being valued” to improve patient outcomes. By emulating the look and feel of home furnishings, the Prodigy line helps make the challenging environment of behavioral health facilities more conducive to patient health.

The Prodigy collection features concealed hardware, rounded edges, and an anti-ligature design. Because it can be installed flush to the walls, it provides added security from being contraband-resistant and tamper-resistant. The Prodigy collection includes options for a platform bed, open chest, desk, and nightstand, all made with recycled materials and is fully recyclable. Its non-porous, one-piece assembly is designed for easy cleaning and can withstand frequent bleach cleaning or hospital-grade disinfectants for infection control.

For more information on the Prodigy line, visit Norix.com

About Norix

For more than 35 years, Norix has designed robust furniture that meets the real-world need for humanizing challenging environments. We pride ourselves in creating products that serve the healthcare, higher education, shelter and corrections industry in ways that make those environments safe and secure. Learn more at http://www.norix.com.

For Immediate Release

Contact: Peter Graves, Norix

630-231-1331

Laura McGowan, The McGowan Group

630-863-8709

Share article on social media or email:

De-risking Clinical Development by Obtaining Key Patient Data Earlier, Upcoming Webinar Hosted by Xtalks


Xtalks Life Science Webinars

The presenters will discuss how different regulatory and operational strategies were employed to optimise trial efficiency, minimise regulatory review timeframes and maximise recruitment efforts of early phase patient studies.

In this webinar, members of Simbec-Orion’s specialist early phase Project Management team will discuss how they tackled a range of challenges to successfully execute a variety of Phase I clinical studies in patient populations.

The presenters will discuss how different regulatory and operational strategies were employed to optimise trial efficiency, minimise regulatory review timeframes and maximise recruitment efforts of early phase patient studies. These will be demonstrated via a number of case studies including:


  • A First-into-Human study combining healthy volunteer and rare disease patient population parts within the same protocol
  • A human pharmacology study involving patients with neurodegenerative disease
  • A gamma-scintigraphy imaging/inhaled drug lung distribution study in patients with moderate and severe chronic obstructive pulmonary disease (COPD)

Join Nadine Aawar, Director Project Management, Laura Llewellyn, Project Director, and Laura Galligan, Project Manager at Simbec-Orion in a live webinar on Wednesday, July 29, 2020 at 9am EDT (2pm BST/UK).

For more information or to register for this event, visit Phase I Studies in Patient Populations: De-risking Clinical Development by Obtaining Key Patient Data Earlier.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

CAMC General Hospital has the Best Value Outcomes for Renal Failure in Charleston, WV


Best Value Outcomes for Renal Failure in Charleston, WV

“Dexur’s value analysis tracks a patient’s episode of care from the date of admission for 90 days and includes the index hospitalization, rehospitalization, home health, nursing home, and ED costs.”

Dexur’s analysis of Medicare claims of hospitals within a 50-mile radius of Charleston, West Virginia, showed that CAMC General Hospital had the best value outcomes over a 90-day episode for Renal Failure, followed by Raleigh General Hospital and St. Mary’s Medical Center. Dexur’s value analysis tracks a patient’s episode of care from the date of admission for 90 days, including the index hospitalizations, rehospitalization, home health, nursing home, and ED costs. The total cost of care data helps patients make appropriate choices and helps local ACOs such as CAMC Health Network, LLC, make appropriate referrals choices. The analysis was risk-adjusted, for alive and non-hospice patients and was done at the DRG level, specifically DRG 683: Renal Failure with Complication or Comorbidity, to adjust for complications and comorbidities.

CAMC General Hospital’s total cost of care over a 90-day episode was $18,619 (for the period between July 2016 to June 2019). The index hospitalization cost was $7,160 and the average rehospitalization cost was $7,561. The cost per rehospitalization was at an average of $17,888. Meanwhile, the average ED costs per hospitalization (when ED is involved) was $1,017.

Raleigh General Hospital’s total cost of care over a 90-day episode was $18,940 (for the period between July 2016 to June 2019). The index hospitalization cost was $6,017 and the average rehospitalization cost was $8,749. The cost per rehospitalization was at an average of $21,249. Meanwhile, the average ED costs per hospitalization (when ED is involved) was $864.

St. Mary’s Medical Center’s total cost of care over a 90-day episode was $18,948 (for the period between July 2016 to June 2019). The index hospitalization cost was $6,530 and the average rehospitalization cost was $7,938. The cost per rehospitalization was at an average of $20,331. Meanwhile, the average ED costs per hospitalization (when ED is involved) was $1,046.

Share article on social media or email:

Mid Coast Hospital, Southern Maine Health Care, and Central Maine Medical Center have the Best Value Outcomes for Sepsis in Portland, ME


Best Value Outcomes for Sepsis in Portland, ME

“Dexur’s value analysis tracks a patient’s episode of care from the date of admission for 90 days and includes the index hospitalization, rehospitalization, home health, nursing home, and ED costs.”

Dexur’s analysis of medicare claims of hospitals within a 50-mile radius of Portland, ME, showed that Mid Coast Hospital, Southern Maine Health Care, and Central Maine Medical Center had the best value outcomes over a 90-day episode for Sepsis. The episode of care tracks a patient journey from the date of admission for 90 days and includes the index hospitalizations, rehospitalization, home health, nursing home, and ED costs. The total cost of care data helps patients make appropriate choices and helps local ACOs such as MaineHealth Accountable Care Organization to make appropriate referrals choices. The analysis was risk-adjusted, for alive and non-hospice patients and was done at the DRG level, specifically DRG 871: Septicemia Or Severe Sepsis Without MV >96 Hours With Major Complication Or Comorbidity (MCC), to adjust for complications and comorbidities.

Mid Coast Hospital’s total cost of care over a 90 day episode was $22,526 (for the period between July 2016 and June 2019). The index hospitalization cost was $11,652 and the average rehospitalization cost per hospitalization was $5,798. The cost per rehospitalization was at an average of $19,668. Meanwhile, the average ED costs per hospitalization (when ED is involved) was $917.

The average home health cost per hospitalization when a home health agency is involved was $3,592. The average cost per hospitalization for the top home health agency partner for Sepsis for Mid Coast Hospital was:

Southern Maine Health Care’s total cost of care over a 90 day episode was $22,944 (for the period between July 2016 and June 2019). The index hospitalization cost was $11,339 and the average rehospitalization cost per hospitalization was $6,571. The cost per rehospitalization was at an average of $22,852. Meanwhile, the average ED costs per hospitalization (when ED is involved) was $847.

Central Maine Medical Center’s total cost of care over a 90 day episode was $23,263 (for the period between July 2016 and June 2019). The index hospitalization cost was $11,865 and the average rehospitalization cost per hospitalization was $6,460. The cost per rehospitalization was at an average of $20,487. Meanwhile, the average ED costs per hospitalization (when ED is involved) was $1,347.

Share article on social media or email:

Integrating Qualitative Patient Interviews into a Clinical Trial Protocol, Upcoming Webinar Hosted by Xtalks


Xtalks Life Science Webinars

In the era of patient-centred research and healthcare, clinical researchers are being asked to think beyond hypothesis testing, and to engage in sometimes-difficult discussions about the meaningfulness of their trial results.

Join Benoit Arnould, Divisional Principal, Patient Centred Outcomes, ICON plc, Alexia Marrel, Lead Outcomes Researcher, Patient Centred Outcomes, ICON plc and Olga Moshkovich, Lead Outcomes Researcher, Patient Centred Outcomes, ICON plc in a live webinar on Thursday, July 30 at 11am EDT (4pm BST/UK).

In the era of patient-centred research and healthcare, clinical researchers are being asked to think beyond hypothesis testing, and to engage in sometimes-difficult discussions about the meaningfulness of their trial results. Regulators, payers, clinicians and patient advocacy groups all want to understand how innovative products and treatments can change the course of disease, and how patients will experience and value these changes.

The recent draft guidance issued by FDA (Oct 2019) “Patient-Focused Drug Development: Methods to Identify What Is Important to Patients” encourages industry to conduct qualitative research. While most stakeholders recognise the unique value of qualitative research, and researchers have strong qualitative methods to capture and report subjective experience communicated with natural language, adapting and integrating this into sophisticated clinical trials is not always straightforward.

Join this webinar for insights on how to include qualitative research into your trials more effectively. Experts from ICON plc will share knowledge from over five years of successfully designing and conducting entry and exit interviews in clinical trials, and discuss the solid and emerging set of scientific publications available to support this approach.

For more information or to register for this event, visit Integrating Qualitative Patient Interviews into a Clinical Trial Protocol.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

The Orthopaedic Research and Education Foundation, the Scoliosis Research Society and the Pediatric Orthopaedic Society of North America award $240,000 spine grants


Children playing soccer

“The 2020 OREF/SRS/POSNA Transform Practice – Spinal Growth Research Grant program is an exceptional grant with respect to closing critical knowledge gaps in spine deformity in children.”

The Orthopaedic Research and Education Foundation (OREF), the Scoliosis Research Society (SRS) and the Pediatric Orthopaedic Society of North America (POSNA) announced today that research grants of $240,000 have been awarded to Stuart L. Weinstein, MD, of the University of Iowa, Iowa City, Iowa, and Carol A. Wise, PhD, of Texas Scottish Rite Hospital for Children, Dallas. Both investigators received an OREF/SRS/POSNA Transform Practice – Spinal Growth Grant.

Dr. Weinstein’s study, Bracing vs Casting in the Treatment of Idiopathic Early-Onset Scoliosis, seeks to establish the relative short-term effectiveness of casting and bracing in the treatment of idiopathic early-onset scoliosis (IEOS, onset at less than 3 years of age). Despite widespread use, neither of these approaches has been rigorously tested in the IEOS population, leading to the current lack of consensus within the orthopaedic community about the preferred approach.

Dr. Wise’s study, Translating Genomics into Early Onset Scoliosis (EOS) Clinical Care, addresses a condition that encompasses a heterogeneous population representing many underlying genetic etiologies, all with potential for the most severe scoliosis phenotypes when untreated. Perhaps the most frustrating are the so-called idiopathic “infantile” scoliosis (IIS) patients who are severely disfigured but apparently healthy otherwise. This pilot study seeks to discover novel EOS disease genes and uncover new underlying etiologies in this unique patient population.

OREF Research Grants Committee (RGC) chair, Francis Y. Lee, MD, PhD, noted, “The 2020 OREF/SRS/POSNA Transform Practice – Spinal Growth Research Grant program is an exceptional grant with respect to closing critical knowledge gaps in spine deformity in children. It provides significant funding for studies that have been vetted through OREF’s NIH-level peer review process.” Dr. Lee also expressed his gratitude to Brian Snyder, MD, PhD, an NIH-funded clinician-scientist and the OREF Program Director for this grant, stating, “Dr. Snyder did an outstanding job leading the peer-review process and holding a study section review. His contribution to the grant selection process was invaluable and it was an honor to work with him.”

The grant is part of OREF’s Collaborative Research Agenda program, which seeks to bring together stakeholders who share an interest in improving orthopaedic care to identify, prioritize and fund topics that are especially relevant to clinical practice today. “This grant is highly important as the SRS seeks to collaborate and direct research in priority areas. There is nothing more important than improving the treatment of deformity in our youngest patients,” said Paul D. Sponseller, MD, MBA, SRS President.

POSNA President, Michael Vitale, MD, MPH, noted, “The clinical knowledge garnered from these two grants, as well as from the myriad grant applications which could not be funded at this time but which still may come to fruition, will serve to advance the evolution of care in this space. OREF, POSNA and SRS are proud to be able to partner to create this opportunity.”

Funding for the grants was provided by Dr. John and Mrs. Kim Callaghan, SRS, POSNA, Medtronic Inc., DePuy Synthes and Zimmer Biomet.

About the Orthopaedic Research and Education Foundation

The Orthopaedic Research and Education Foundation is a charitable 501(c)(3) organization committed to improving lives by supporting excellence in orthopaedic research. OREF is dedicated to being the leader in supporting research that improves function, eliminates pain, and restores mobility, and is the premier orthopaedic organization funding research across all subspecialties. A list of research and funding priorities is available at https://www.oref.org/grants or by following OREF on Twitter at https://twitter.com/OREFtoday.

About the Scoliosis Research Society

The Scoliosis Research Society is a non-profit, professional organization made up of physicians and allied health personnel. Its primary focus is on providing continuing medical education for health care professionals and on funding/supporting research in spinal deformities. Founded in 1966, SRS has gained recognition as the world’s premier spine deformity society. Please visit http://www.srs.org for further information.

About the Pediatric Orthopaedic Society of North America

The Pediatric Orthopaedic Society of North America (POSNA) is a not-for-profit professional organization of over 1,400 surgeons, physicians, and allied health members passionately dedicated to advancing musculoskeletal care for children and adolescents through education, research, quality, safety and value initiatives, advocacy, and global outreach to children in underserved areas. For more information, visit https://posna.org/.

Share article on social media or email:



Two weeks is how long it took to create an application that could save lives during the COVID-19 pandemic


Can technological innovation be the answer to the crisis caused by COVID-19? Startup Development House proves it is possible. To create a modern solution, limited resources are enough and short delivery time does not have to be a problem at all. The key is agile management.

Innovation in two weeks? It’s possible!

Grace Lake Partners (GLP), a company from Nigeria, asked Startup Development House to create a mobile application to help fight the pandemic. The coronavirus loves when we move around and gather in one place, so this should be avoided. The SocialHealth application helps you arrange a remote doctor’s appointment, make a video call and issue a digital prescription. Less than two weeks have passed since signing the contract and the solution has already been implemented. It’s the first application of this kind in Nigeria.

A serious challenge and flexible approach

How to achieve record-breaking time for design and implementation? Experience in creating IT solutions for startups proves to be priceless. The answer is precisely recognising the client’s needs, rapid prototyping and using the right technologies. Innovation requires us to focus on what is most important for the users, create a prototype and then choose a simple solution. In this case, the design of the application was of secondary matter to the client, while the time of development and wide availability for patients and doctors were crucial.

Speed and availability but also safety

SocialHeath is a Progressive Web App (PWA). This means it is available from your browser, so you don’t have to download it from Google Play or the App Store. The process of registering doctors and patients, specifying the symptoms, planning visits or prescribing medicine has been simplified as much as possible. And what’s essential, the application works properly even with a weak Internet connection. Startup Development House has also taken into account a requirement specific for Nigeria, so the e-prescription includes the doctor’s signature. In two weeks, they have created a solution that is not only user-friendly but also fully secure. All connections and patient data are encrypted. The provider was able to fulfill this requirement basing on previous experience with corporate innovation.

Digital innovation and pandemic

Nigeria is currently facing not only the COVID-19 pandemic but also other infectious diseases. That’s why it is essential that only patients who really have to be there, are in the clinics. The coronavirus forces governments and entrepreneurs to take an innovative approach to problem-solving. Implementing remote work and organising medical ‘televisits’ is a new trend but not the only one. The situation related to the pandemic also has a significant impact on other sectors, such as gastronomy, selling groceries or financial services. Entities that have previously invested in digital transformation are certainly better prepared to face the crisis. For others, it may be crucial to make a quick decision to establish a cooperation with a partner who will develop a new product concept with them, create a prototype and then successfully implement a ready-to-use IT solution.

How to find the right partner?

Matrimonial associations work perfectly here, as we can be involved with an IT partner for a long time (depending on our needs). What’s worth paying attention to?

1. Portfolio. Checking their completed projects and other clients’ opinions is a significant part of due diligence. A technology partner with experience in working with both start-ups and large companies can successfully combine fast methods of digital project implementation with growing business needs.

2. Project management methods. In a dynamically changing environment (as we’re all experiencing now), our partner should be agile, i.e. proficient in implementations using modern methods, such as Agile, Scrum. This guarantees that the project will be delivered within a given budget and timeline.

3. The team’s knowledge of modern technologies. To quickly implement digital solutions from A to Z, our partner should have a complete team of specialists: developers, product strategists, product designers, project managers and quality assurance testers. Technology is key but its selection depends on the client’s specific needs. The success of a product or IT solution consists of combining all competencies “under one roof”.

4. Experience with international projects. This ensures the contractor combines their agile approach with good communication and an emphasis on system security. It also demonstrates the ability to work efficiently remotely which, especially nowadays, is a prerequisite for work continuity and can determine the success of a project.

A departure from the traditional model of long-lasting IT implementations made according to the so-called “specifications” towards rapid prototyping and implementing user-tested digital solutions is inevitable. Even more so in times when helping the client determine their needs and efficient workflows are more important than writing another line of code.

Share article on social media or email:

Smartlogic is Named as one of KMWorld’s AI50 – Companies Empowering Intelligent Knowledge Management


News Image

Smartlogic, The leader in Semantic AI solutions, has been named as one of KMWorld’s AI50 – Companies Empowering Intelligent Knowledge Management. This distinction is given to organizations with innovative knowledge management solutions that are incorporating AI and cognitive computing technologies into their offerings.

With more than 25 years of market coverage experience serving both technology professionals and executive management, KMWorld is the premier resource for actionable advice and real direction on solutions and strategies in knowledge, content, document and information management today. From advanced news and trends analysis to case studies and in-depth research, KMWorld guides more than 50,000 IT and business professionals at organizations across North America involved in the evaluation, recommendation, and purchase of enterprise technology products and services.

“We are excited to be recognized as part of KMWorld’s AI50. As the drive for digital transformation becomes imperative for organizations who want to compete and succeed in today’s digital economy, the need for intelligent technologies and services that enable speed, insight, and accuracy becomes key. That our product is recognized by KMWorld as one that provides the capabilities organizations need to thrive in an ever-changing economy is indeed high praise.” says Jeremy Bentley, CEO Smartlogic.

Semaphore, our Semantic AI platform, is designed for the world’s largest enterprises who demand scale and quality, it combines the power of Semantic AI with award-winning knowledge model management, precise classification and language services, and cutting-edge fact extraction capabilities.

Semaphore delivers more value to enterprise initiatives that require the aggressive use of data – structured and unstructured, internal and external to the organization. Organizations leverage Semaphore to capitalize on information across governance and compliance, provide excellent customer experiences, and gain valuable insights from previously unavailable information to drive new revenue streams, gain organizational efficiencies, and achieve cost savings.

About Smartlogic

Smartlogic’s Semaphore is a Semantic AI platform that enables organizations to reveal and extract knowledge from their digital data ecosystem to yield business insight. Semaphore enriches enterprise information with context and meaning, extracts critical facts and relationships, and harmonizes disparate enterprise information. Semaphore Integrates with content, data, and application systems; supports multiple data types – including graph – and incorporates AI and machine learning strategies to transform digital data into qualified actionable intelligence.

Semaphore is available on-premise; Software as a Service (SaaS); on-Demand and in hybrid mode. We support the information needs of the world’s largest enterprises to accelerate growth, prevent revenue leakage, minimize risk, govern enterprise information, and deliver value to their organization, customers, partners, and suppliers.

Share article on social media or email:

Nutrition Digital Health Startup Nutrimedy Partners with TechSpring at Baystate Health to Support Oncology Patients


As part of it’s expansion of their Digital Health R&D Sandbox Program, Massachusetts eHealth Institute (MeHI) has announced that it has awarded a grant to TechSpring, the Baystate Health Technology Innovation Center. This grant will enable them to work with Nutrimedy ,“…to access TechSpring’s product development acceleration services and work with experienced Innovation Managers to test and validate their products in a real healthcare environment.”

Nutrimedy’s mission is to improve health and reduce the epidemic burden of chronic disease by improving access to convenient, expert, personalized and affordable nutritional counseling. Through the grant, Nutrimedy, based in Brookline, will work with TechSpring’s Innovation Managers to complete the discovery, planning, and execution of a pilot project that will provide Nutrimedy’s patient-facing nutritional support platform to oncology patients at Baystate Health pre-surgery. Nutrimedy will work with TechSpring and Baystate Health to gather user feedback from the participating patients and clinicians and to assess the effectiveness in Nutrimedy’s platform in helping increase patients’ access to clinical nutrition care and to reach their pre-surgical nutritional goals.

“There is a high prevalence of malnutrition in cancer patients, with some studies showing that as many as 80% of patients have some degree of malnutrition. Access to clinical nutrition care through Nutrimedy will allow patients to connect with a dietitian remotely and be proactively managed prior to surgery,” said Karolina Starczak, CEO of Nutrimedy.

The funding for the Sandbox Program is part of Massachusetts’ “…efforts to boost the digital health ecosystem under the Massachusetts Digital Health Initiative.” This grant will allow Nutrimedy to access TechSpring’s unique innovation environment to more quickly test, validate, and advance their product. “The mutual benefit of working with Nutrimedy is that we get to learn together how to scale these types of digital tools,” said Jill McCormick, Director of Design and Innovation at TechSpring, based in Springfield, Mass.

Mallory Franklin, Chief Clinical Officer of Nutrimedy, spearheaded the effort to receive the Sandbox Grant. She says, “Cancer-related malnutrition is the cause of death in as many as 40% of cancer patients and providing clinical nutrition care through telehealth can remove barriers to access for patients. That’s why with the support of the Sandbox Program, we are thrilled to be working with Baystate Health and TechSpring to provide an innovative approach to connecting patients to the care they need through Nutrimedy’s digital health platform.”

About Nutrimedy:

Nutrimedy is a digital health company focused on the next generation of evidence- based clinical nutrition care to provide real-time at-point recommendations and decision making assistance to patients using a virtual model. Nutrimedy provides longitudinal support and guidance for over 50 conditions through built-in video appointments with registered dietitians, secure messaging, file sharing, educational content, customizable trackers and AI-enabled photo food logging. To find out more visit http://www.nutrimedy.com

About TechSpring, Baystate Health’s Technology Innovation Center:

TechSpring is a technology innovation organization that, with direct connection to Baystate Health, https://www.baystatehealth.org/, a large integrated health system, provides leading technology companies with access to real healthcare resources and a representative community to test, prove, and accelerate their innovative solutions. The TechSpring Insights program connects innovators directly to users and other sources critical to drive and validate product development and adoption and to go to market with a competitive advantage. Learn more about TechSpring goat https://www.techspringhealth.org/ and follow @TechSpringMA on Twitter.

About the Massachusetts eHealth Institute:

MeHI, or the Massachusetts eHealth Institute at the Massachusetts Technology Collaborative, is the Commonwealth’s entity for healthcare innovation, technology, and competitiveness, and partners with industry, government, and healthcare organizations to support the Massachusetts Digital Health Initiative on behalf of the Baker-Polito Administration. MeHI also helps Massachusetts healthcare providers harness the benefits of electronic health records and the Mass HIway, the statewide health information exchange. For more information, please visit https://mehi.masstech.org and follow @MassEHealth. Learn more about the Massachusetts Digital Health Initiative at http://www.massdigitalhealth.org.

Share article on social media or email: